The competitive KU70 binding by these proteins affects cancer cells' ability to repair broken DNA and acquire resistant genetic mutations in CML and prostate cancer cells. The gene discussed is XRCC6; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.